Hematologic Malignancies: Clinical Trials

1 trial for Hematologic Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer
Phase 4Not yet recruitingHospital Universitari Vall d'Hebron Research Institute1362026-06-012026-05-15

Narrower conditions

Febrile Neutropenia (1)  ·  Hematologic Neoplasms (1)  ·  Neoplasms (1)  ·  Neutropenia (1)

Broader conditions

Agranulocytosis (1)  ·  Cytopenia (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)  ·  Neoplasms by Site (1)

Interventions

Amikacin (1)  ·  Cefepime (1)  ·  Ceftazidime (1)  ·  Ciprofloxacin (1)  ·  Meropenem (1)  ·  Metronidazole (1)  ·  Ofloxacin (1)  ·  Teicoplanin (1)  ·  Vancomycin (1)

Sponsors

Hospital Universitari Vall d'Hebron Research Institute (1)

Countries

Spain (1)